Identification of potent and selective MMP-13 inhibitors
Wu, J., Rush III, T.S., Hotchandani, R., Du, X., Geck, M., Collins, E., Xu, Z.B., Skotnicki, J., Levin, J.I., Lovering, F.E.(2005) Bioorg Med Chem Lett 15: 4105-4109
- PubMed: 16005220 
- DOI: https://doi.org/10.1016/j.bmcl.2005.06.019
- Primary Citation of Related Structures:  
1ZTQ - PubMed Abstract: 
A potent, selective series of MMP-13 inhibitors has been derived from a weak (3.2 microM) inhibitor that did not bear a zinc chelator. Structure-based drug design strategies were employed to append a Zn-chelating group to one end of the molecule and functionality to enhance selectivity to the other. A compound from this series demonstrated rat oral bioavailability and efficacy in a bovine articular cartilage explant model.
Organizational Affiliation: 
Department of Chemical and Screening Sciences, Wyeth Research, 200 Cambridge Park Drive, Cambridge, MA 02140, USA.